Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast Cancer: A Retrospective Analysis of the MONARCH 2 Trial.

MLA

Gerratana, Lorenzo, et al. “Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast Cancer: A Retrospective Analysis of the MONARCH 2 Trial.” Oncologist, vol. 29, no. 2, Feb. 2024, pp. 123–31. EBSCOhost, https://doi.org/10.1093/oncolo/oyad293.

APA

Gerratana, L., Kocherginsky, M., Davis, A. A., D’Amico, P., Reduzzi, C., Puglisi, F., & Cristofanilli, M. (2024). Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast Cancer: A Retrospective Analysis of the MONARCH 2 Trial. Oncologist, 29(2), 123–131. https://doi.org/10.1093/oncolo/oyad293

Chicago

Gerratana, Lorenzo, Masha Kocherginsky, Andrew A Davis, Paolo D’Amico, Carolina Reduzzi, Fabio Puglisi, and Massimo Cristofanilli. 2024. “Circulating Tumor Cells Prediction in Hormone Receptor Positive HER2-Negative Advanced Breast Cancer: A Retrospective Analysis of the MONARCH 2 Trial.” Oncologist 29 (2): 123–31. doi:10.1093/oncolo/oyad293.